Deep learning-guided selection of antibody therapies with enhanced resistance to current and prospective SARS-CoV-2 Omicron variants
L. Frei, B. Gao, J. Han, J. M. Taft, E. B. Irvine, C. R. Weber, R. Kumar, B. Eisinger, S. T. Reddy
This study uses deep learning to identify antibodies resistant to SARS-CoV-2 Omicron variants by predicting their binding and escape from mutations.
bioRxiv · Oct 9, 2023 · PreprintImmunology